Drug Nephrotoxicity Test

About Mosaique Diagnostic

Mosaique Diagnostic is a pioneer in clinical proteomics, leveraging its unique CE-MS platform to decode disease-specific peptide patterns from urine. Its core focus is the early, non-invasive detection and monitoring of chronic diseases, primarily in nephrology, oncology, and cardiology, enabling personalized medicine approaches. The company has commercialized several diagnostic tests in Germany through its subsidiary and maintains an extensive global academic and industry collaboration network. Its technology is backed by a robust publication record and a large proprietary database of human urinary proteome data.

Therapeutic Areas